Spectrum of clonal hematopoiesis in VEXAS syndrome

F Gutierrez-Rodrigues, Y Kusne… - Blood, The Journal …, 2023 - ashpublications.org
Abstract Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is
caused by somatic mutations in UBA1 (UBA1 mut) and characterized by heterogenous …

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

IE Obiorah, BA Patel, EM Groarke, W Wang… - Blood …, 2021 - ashpublications.org
Somatic mutations in UBA1 involving hematopoietic stem and myeloid cells have been
reported in patients with the newly defined VEXAS (vacuoles, E1 enzyme, X-linked …

Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome

N Patel, A Dulau-Florea, KR Calvo - Seminars in Hematology, 2021 - Elsevier
Abstract VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a newly
characterized syndrome with underlying somatic UBA1 mutations in myeloid cells linking …

VEXAS syndrome: clinical, hematologic features and a practical approach to diagnosis and management

MJ Koster, TL Lasho, H Olteanu… - American journal of …, 2024 - Wiley Online Library
Abstract VEXAS (Vacuoles, E1 enzyme, X‐linked, Autoinflammatory, Somatic) syndrome is a
newly identified disease caused by somatic alterations in UBA1 which produce a recalcitrant …

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder

H Huang, W Zhang, W Cai, J Liu, H Wang, T Qin… - … Hematology & Oncology, 2021 - Springer
Abstract VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a
newly-described adult-onset inflammatory syndrome characterized by vacuoles in myeloid …

VEXAS syndrome: a novelty in MDS landscape

M Templé, O Kosmider - Diagnostics, 2022 - mdpi.com
Fever, inflammation and vacuoles in hematopoietic cells represent the main features
associated with VEXAS syndrome, a new prototype of autoinflammatory disorders …

Toward a pathophysiology inspired treatment of VEXAS syndrome

M Heiblig, BA Patel, EM Groarke, E Bourbon… - Seminars in …, 2021 - Elsevier
VEXAS syndrome has an unmet need for therapeutic interventions. Even if few data exist
regarding the treatment of this newly described syndrome, different options can be proposed …

Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS

Z Wu, S Gao, Q Gao, BA Patel, EM Groarke, X Feng… - Cell Reports …, 2023 - cell.com
Summary VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a
pleiotropic, severe autoinflammatory disease caused by somatic mutations in the ubiquitin …

Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience

A Diarra, N Duployez, E Fournier… - Blood …, 2022 - ashpublications.org
The recently described vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS)
syndrome is caused by somatic mutations in UBA1. Patients with VEXAS syndrome display …

Therapeutic options in VEXAS syndrome: insights from a retrospective series

E Bourbon, M Heiblig… - Blood, The Journal …, 2021 - ashpublications.org
Therapeutic options in VEXAS syndrome: insights from a retrospective series | Blood | American
Society of Hematology Skip to Main Content Advertisement Umbrella Alt Text Umbrella Alt Text …